Global Pemetrexed Drug Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Table of Contents

1 Pemetrexed Drug Market Overview

• 1.1 Product Overview and Scope of Pemetrexed Drug
• 1.2 Classification of Pemetrexed Drug by Types
  • 1.2.1 Global Pemetrexed Drug Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Pemetrexed Drug Revenue Market Share by Types in 2018
  • 1.2.3 100 mg lyophilized powder/vial
  • 1.2.4 500 mg lyophilized powder/vial
• 1.3 Global Pemetrexed Drug Market by Application
  • 1.3.1 Global Pemetrexed Drug Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Pleural mesothelioma
  • 1.3.3 Non-small cell lung cancer
• 1.4 Global Pemetrexed Drug Market by Regions
  • 1.4.1 Global Pemetrexed Drug Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Pemetrexed Drug Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Pemetrexed Drug Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pemetrexed Drug Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Pemetrexed Drug Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pemetrexed Drug Status and Prospect (2014-2024)
• 1.5 Global Market Size of Pemetrexed Drug (2014-2024)

2 Manufacturers Profiles

• 2.1 Eli Lilly and Company
  • 2.1.1 Business Overview
  • 2.1.2 Pemetrexed Drug Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Eli Lilly and Company Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Pfizer
  • 2.2.1 Business Overview
  • 2.2.2 Pemetrexed Drug Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Pfizer Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Teva
  • 2.3.1 Business Overview
  • 2.3.2 Pemetrexed Drug Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Teva Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Eagle Pharmaceuticals
  • 2.4.1 Business Overview
  • 2.4.2 Pemetrexed Drug Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Eagle Pharmaceuticals Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 APOTEX
  • 2.5.1 Business Overview
  • 2.5.2 Pemetrexed Drug Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 APOTEX Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Qilu Pharmaceutical
  • 2.6.1 Business Overview
  • 2.6.2 Pemetrexed Drug Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Qilu Pharmaceutical Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Biocon
  • 2.7.1 Business Overview
  • 2.7.2 Pemetrexed Drug Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Biocon Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)

3 Global Pemetrexed Drug Market Competition, by Players

• 3.1 Global Pemetrexed Drug Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Pemetrexed Drug Players Market Share
  • 3.2.2 Top 10 Pemetrexed Drug Players Market Share
• 3.3 Market Competition Trend

4 Global Pemetrexed Drug Market Size by Regions

• 4.1 Global Pemetrexed Drug Revenue and Market Share by Regions
• 4.2 North America Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 4.3 Europe Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 4.5 South America Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Pemetrexed Drug Revenue and Growth Rate (2014-2019)

5 North America Pemetrexed Drug Revenue by Countries

• 5.1 North America Pemetrexed Drug Revenue by Countries (2014-2019)
• 5.2 USA Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 5.3 Canada Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Pemetrexed Drug Revenue and Growth Rate (2014-2019)

6 Europe Pemetrexed Drug Revenue by Countries

• 6.1 Europe Pemetrexed Drug Revenue by Countries (2014-2019)
• 6.2 Germany Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 6.3 UK Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 6.4 France Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 6.5 Russia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 6.6 Italy Pemetrexed Drug Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Pemetrexed Drug Revenue by Countries

• 7.1 Asia-Pacific Pemetrexed Drug Revenue by Countries (2014-2019)
• 7.2 China Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 7.3 Japan Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 7.4 Korea Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 7.5 India Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Pemetrexed Drug Revenue and Growth Rate (2014-2019)

8 South America Pemetrexed Drug Revenue by Countries

• 8.1 South America Pemetrexed Drug Revenue by Countries (2014-2019)
• 8.2 Brazil Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Pemetrexed Drug Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Pemetrexed Drug by Countries

• 9.1 Middle East and Africa Pemetrexed Drug Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 9.3 UAE Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Pemetrexed Drug Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Pemetrexed Drug Revenue and Growth Rate (2014-2019)

10 Global Pemetrexed Drug Market Segment by Type

• 10.1 Global Pemetrexed Drug Revenue and Market Share by Type (2014-2019)
• 10.2 Global Pemetrexed Drug Market Forecast by Type (2019-2024)
• 10.3 100 mg lyophilized powder/vial Revenue Growth Rate (2014-2024)
• 10.4 500 mg lyophilized powder/vial Revenue Growth Rate (2014-2024)

11 Global Pemetrexed Drug Market Segment by Application

• 11.1 Global Pemetrexed Drug Revenue Market Share by Application (2014-2019)
• 11.2 Pemetrexed Drug Market Forecast by Application (2019-2024)
• 11.3 Pleural mesothelioma Revenue Growth (2014-2019)
• 11.4 Non-small cell lung cancer Revenue Growth (2014-2019)

12 Global Pemetrexed Drug Market Size Forecast (2019-2024)

• 12.1 Global Pemetrexed Drug Market Size Forecast (2019-2024)
• 12.2 Global Pemetrexed Drug Market Forecast by Regions (2019-2024)
• 12.3 North America Pemetrexed Drug Revenue Market Forecast (2019-2024)
• 12.4 Europe Pemetrexed Drug Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Pemetrexed Drug Revenue Market Forecast (2019-2024)
• 12.6 South America Pemetrexed Drug Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Pemetrexed Drug Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology